Monoamine oxidase type B inhibitors (rasagiline, selegiline and safinamide) are a class of medications used in the management of PD, depression, anxiety disorders and panic disorder by MAO which is responsible for the metabolism of dopamine. The gene discussed is MAOB; the disease is Parkinson disease.